Profiling and semi-quantitation of urine sulfatides by UHPLC-Orbitrap-HRMS

Publication date

2025-05-08

Authors

van der Ham, Maria
Hoytema van Konijnenburg, E. M.M.
van Rossum, Wouter
Gerrits, Johan
van Hasselt, Peter MISNI 0000000390358104
Prinsen, Hubertus C M TISNI 0000000389496593
Jans, Judith J MORCID 0000-0003-0960-6263ISNI 0000000395854262
Schlotawa, Lars
Laugwitz, Lucia
de Sain-van der Velden, Monique G. M.ISNI 0000000392421699

Editors

Advisors

Supervisors

Document Type

Article
Open Access logo

License

cc_by

Abstract

Background: Sulfatides are a class of sphingolipids which are abundant in the myelin sheet and oligodendrocytes, therefore they play a crucial role in the nervous system. Abnormal sulfatide excretion has been linked to several neurodegenerative disorders including metachromatic leukodystrophy (MLD) and multiple sulfatase deficiency (MSD). In MLD and MSD, sulfatide catabolism is impaired due to the reduced lysosomal arylsulfatase A (ARSA) activity resulting in an accumulation of sulfatides, which can be useful in a diagnostic setting. The current study aims to develop a method for semi-quantitation of urine sulfatides as a diagnostic tool for MLD and MSD. Results: We developed a sensitive and accurate method for identifying 48 urinary molecular sulfatide species by UHPLC-Orbitrap-HRMS analysis. Newborns were classified according to their gestational age. The proportion of sulfatides bearing saturated fatty acids attached to d18:1 and d18:0 sulfatide backbone was higher in newborns and increased with prematurity. The 5 most abundant sulfatide species in all samples (controls, MLD and MSD) were C22:0, C24:0, C22:0-OH, C24:0-OH and C24:1-OH fatty acid attached to d18:1 sulfatide backbone. The top discriminant feature between MLD patients and controls was d18:1/C26:1-OH. Total semi-quantitation of 6 sulfatide species (5 most abundant sulfatides + d18:1/C26:1-OH) shows that overall excretion gradually decreases with age and all MLD patients were successfully discriminated from their age-matched controls. While sulfatide excretion was increased in the severe MSD patients (n = 2), it was normal in the attenuated MSD patients, who had high residual ARSA activity. Significance: This study proves the feasibility of diagnosing MLD and severe MSD based on sulfatide excretion in urine. We established (gestational) age-specific cut-offs of the total sulfatide excretion and composition. Interpretation of the composition (e.g. by calculation the ratio (d18:1/C22:0+d18:1/C24:0)/(d18:1/C22:0-OH + d18:1/C24:0-OH)) may reduce false positives, especially when sampling at young age.

Keywords

Metachromatic leukodystrophy, Multiple sulfatase deficiency, Sulfatide excretion, UHPLC-Orbitrap-HRMS, Analytical Chemistry, Environmental Chemistry, Biochemistry, Spectroscopy, Journal Article

Citation

van der Ham, M, Hoytema van Konijnenburg, E, van Rossum, W, Gerrits, J, van Hasselt, P, Prinsen, H, Jans, J, Schlotawa, L, Laugwitz, L & de Sain-van der Velden, M 2025, 'Profiling and semi-quantitation of urine sulfatides by UHPLC-Orbitrap-HRMS', Analytica Chimica Acta, vol. 1350, 343824. https://doi.org/10.1016/j.aca.2025.343824